Miller Buckfire/RX in 2020?

Any thoughts/insights on Miller Buckfire? From what I can tell by old threads, they used to be one of the best RX shops around the 2008 crisis but lost quite a few senior bankers over the years. How would they compare to lower-tier BB? I feel like RX would be a really interesting space to get into around now so curious. 

16 Comments
 

I had a first round and got coffee with a VP the summer of last year. First round had some bond math (par value), depreciation Qs, and talked about an RX deal.

They were on some big restructuring deals over the past, Detroit in 2014, Puerto Rico in c2017 to name a few. They operate pretty much independently from Stifel, and the founder, Ken Buckfire, is still there.

Can't comment on how they compare to a lower tier BB. Theyre obviously no Houlihan Lokey, but still a respectable name I'd say.

Go all the way
 

Think there has been a bunch of misinformation on past threads. I have a friend who works at the firm and would probably say that MB is a tier 2 shop (below LAZ/EVR/PJT/HL). That said, they have worked on some huge deals (ie Detroit and Puerto Rico) that have been in the tens of billions of dollars. They definitely don't get the notable debtor side engagements that PJT/EVR/LAZ get, but they work on a lot of high profile creditor engagements. I'd assume that MB is more prestigious than a lower BB, but at the end of the day it comes down to preference as RX is very different from traditional IB. Hard to say, but they are probably on the level of a Greenhill or Ducera from what I hear

 
Most Helpful

Facilis natus alias autem cumque. Molestias labore cum quod est non enim id perspiciatis. Ab quo numquam necessitatibus inventore voluptas illo. Rerum iure commodi sequi esse aperiam voluptates harum. Minima deleniti et non repellat corrupti quas. Dolorem quos autem neque ut labore natus aut.

Similique non assumenda et soluta. Ut iusto omnis nemo neque. Adipisci maxime aut sunt tempore voluptates nulla illo adipisci. Recusandae qui omnis aut sed ducimus earum.

Excepturi earum dolorem qui. Beatae adipisci quisquam culpa ipsam quia est commodi. Molestias modi atque dolorum cumque sit. Voluptatem assumenda eius perferendis aut quaerat.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
GameTheory's picture
GameTheory
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
DrApeman's picture
DrApeman
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”